Jerome Winegarden: ASH Continues to Show Exceptional Leadership by Advocating for Patients With Blood Diseases
Jerome Winegarden, Attending Physician and Hematology Oncology Fellowship Program Director at Trinity Health, reposted from American Society of Hematology on LinkedIn:
”ASH continues to show exceptional leadership by advocating for patients with blood diseases.
Standing up for science is not just a great tag line!
It really means something to the millions of people who suffer from blood cancers and blood related diseases.
I’m so proud to be an ASH member.”
Quoting American Society of Hematology‘s post:
”Boldly Standing Up for Science.
2025 brought unprecedented political threats to scientific research, federal funding, and access to care, but hematology thrived.
Through the hashtag Fight 4 Hematology campaign, the Society stepped up to expand research funding and training opportunities, lead impassioned advocacy efforts, and amplify the voices of clinicians, researchers, and patients.
ASH is proud to serve hematologists who are dedicated to conquering blood diseases and improving the lives of patients around the world.
Thank you for being an ASH member and helping to make 2025 such a success!
View the 2025 ASH Annual Report.”
Stay updated with Hemostasis Today.
-
Jun 25, 2026, 19:32Javier M. Floren: A Blood Clot Is One of the Most Impressive Examples of Teamwork You’ll Ever See
-
Jun 25, 2026, 19:31Marcin Krzysztof Maniak: Linking Tissue Mechanics to Inflammation in Health and Disease
-
Jun 25, 2026, 19:29Deepak Rawat: A Diagnosis Like Immune Thrombocytopenia Changes Your Perspective
-
Jun 25, 2026, 19:27Srikanth R.: Don’t Ignore Your Health While Chasing Success
-
Jun 25, 2026, 19:27Jamie Nash: Delighted to Receive the BBTS Race and Sanger Award 2026
-
Jun 25, 2026, 15:56Wolfgang Miesbach: Building the Future of Gene Therapy – From Centre Readiness to Long-Term Patient Care
-
Jun 25, 2026, 15:46Amber Yates: Making a Meaningful Difference for People Living with Sickle Cell Disease
-
Jun 25, 2026, 15:43Nancy Cavey: Navigating Disability Benefits for Patients with Immune Thrombocytopenia
-
Jun 25, 2026, 15:28Damon Race: Pursuing Long-Term Expression in Hemophilia A Gene Therapy